< Back to search
Filter
1
Active & ResponsiveNew

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)

for
Renal Cell Carcinoma
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06770855

Recruiting
Active & ResponsiveNew

Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)

for
DMG, DIPG
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 3 - 25

Code: NCT07796061

Phase 1, Recruiting
Active & ResponsiveNew

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07659678

Phase 2, Recruiting
Active & ResponsiveNew

TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma

for
Glioblastom WHO Grade 4, GBM, bGBM, Butterfly GBM,
Location: Buffalo NY
Sponsor: Alpheus Medical, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07862647

Phase 1, Recruiting
Active & ResponsiveNew

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

for
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT07430202

Phase 1, Recruiting

Interested in new solid tumors trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer

for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07705919

Phase 1, Phase 2, Recruiting
Active & ResponsiveNew

[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma

for
Cholangiocarcinoma
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07673341

Phase 2, Recruiting
Active & ResponsiveNew

Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome

for
Sturge - Weber Syndrome (SWS)
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 0 - 1

Code: NCT07778810

Phase 2, Recruiting
Active & ResponsiveNew

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

for
Breast Cancer, Tumor, Breast, Breast Tumor,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 18 - 70+

Code: NCT06251544

Phase 1, Recruiting
Active & ResponsiveNew

Older Breast Cancer Patients: Risk for Cognitive Decline

for
Cancer, Breast, Age-related Cognitive Decline,
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: Female

Age: 60 - 70+

Code: NCT03451383

Recruiting
Active & ResponsiveNew

Prehabilitation in High-risk Oncologic Surgery

for
Pancreatic Cancer, Colo-rectal Cancer, Gastric Cancer,
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT07638410

Recruiting
Active & ResponsiveNew

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

for
Glioblastoma, Newly Diagnosed Glioblastoma, Brain Tumor
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT07831772

Recruiting
Active & ResponsiveNew

Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

for
Colorectal Cancer
Location: Toms River NJ, Edison NJ, East Brunswick NJ, Monroe NJ,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07750158

Phase 3, Recruiting
Active & ResponsiveNew

Rutgers University Study of the Genetics of Blood Cancers

for
Blood Cancers, Blood Cancer, Leukemia, Lymphoma, Myeloma,
Location: Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT07714044

Recruiting
Active & ResponsiveNew

JUR-003 in Adult Patients With Metastatic Prostate Cancer

for
Metastatic Castration Resistant Prostate Cancer,
Location: Lake Success NY, Grand Rapids MI, Nashville TN,
Sponsor: Juri Biosciences, Inc.

Sex: Male

Age: 18+

Code: NCT07824349

Phase 1, Recruiting
Active & ResponsiveNew

Language Network Prehab Via fMRI Neurofeedback

for
Glioma, Glioma Surgery
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07488780

Recruiting
Active & ResponsiveNew

CAN1012 in Pre-Malignant DCIS and LCIS

for
Ductal Carcinoma in Situ, Lobular Carcinoma in Situ
Location: Portland OR
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT07408856

Phase 1, Recruiting
Active & ResponsiveNew

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

for
Cutaneous Melanoma
Location: Patchogue NY, Stony Brook NY, Berlin Corners VT,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 70+

Code: NCT07068074

Phase 3, Recruiting
Active & Responsive

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

for
Adenocarcinoma of Lung, Lung Cancer
Location: Duluth MN, Virginia MN, Hibbing MN, Sandstone MN,
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT04105270

Phase 2, Recruiting
Active & Responsive

ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial

for
Endometrial Cancer
Location: Toronto, Edmonton
Sponsor: University of Alberta

Sex: Female

Age: 18+

Code: NCT06038032

Recruiting